<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33976150</PMID><DateCompleted><Year>2021</Year><Month>05</Month><Day>27</Day></DateCompleted><DateRevised><Year>2022</Year><Month>02</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-1723</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>May</Month><Day>11</Day></PubDate></JournalIssue><Title>Nature communications</Title><ISOAbbreviation>Nat Commun</ISOAbbreviation></Journal><ArticleTitle>Comprehensive cell type decomposition of circulating cell-free DNA with CelFiE.</ArticleTitle><Pagination><StartPage>2717</StartPage><MedlinePgn>2717</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">2717</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41467-021-22901-x</ELocationID><Abstract><AbstractText>Circulating cell-free DNA (cfDNA) in the bloodstream originates from dying cells and is a promising noninvasive biomarker for cell death. Here, we propose an algorithm, CelFiE, to accurately estimate the relative abundances of cell types and tissues contributing to cfDNA from epigenetic cfDNA sequencing. In contrast to previous work, CelFiE accommodates low coverage data, does not require CpG site curation, and estimates contributions from multiple unknown cell types that are not available in external reference data. In simulations, CelFiE accurately estimates known and unknown cell type proportions from low coverage and noisy cfDNA mixtures, including from cell types composing less than 1% of the total mixture. When used in two clinically-relevant situations, CelFiE correctly estimates a large placenta component in pregnant women, and an elevated skeletal muscle component in amyotrophic lateral sclerosis (ALS) patients, consistent with the occurrence of muscle wasting typical in these patients. Together, these results show how CelFiE could be a useful tool for biomarker discovery and monitoring the progression of degenerative disease.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Caggiano</LastName><ForeName>Christa</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Bioinformatics Interdepartmental Program, University of California Los Angeles, Los Angeles, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, University of California Los Angeles, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Celona</LastName><ForeName>Barbara</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0001-5391-8155</Identifier><AffiliationInfo><Affiliation>Cardiovascular Research Institute, University of California San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garton</LastName><ForeName>Fleur</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Institute for Molecular Biosciences, University of Queensland, Brisbane, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mefford</LastName><ForeName>Joel</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of California Los Angeles, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Black</LastName><ForeName>Brian L</ForeName><Initials>BL</Initials><Identifier Source="ORCID">0000-0002-6664-8913</Identifier><AffiliationInfo><Affiliation>Cardiovascular Research Institute, University of California San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry and Biophysics, University of California, San Francisco, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Henderson</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurology, Royal Brisbane and Women's Hospital, Brisbane, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lomen-Hoerth</LastName><ForeName>Catherine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of California San Francisco, San Francisco, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dahl</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-6520-4766</Identifier><AffiliationInfo><Affiliation>Section of Genetic Medicine, Department of Medicine, University of Chicago, Chicago, IL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zaitlen</LastName><ForeName>Noah</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0002-3553-3670</Identifier><AffiliationInfo><Affiliation>Department of Neurology, University of California Los Angeles, Los Angeles, CA, USA. nzaitlen@g.ucla.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Computational Medicine, University of California Los Angeles, Los Angeles, CA, USA. nzaitlen@g.ucla.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P01 HL146366</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 ES029929</GrantID><Acronym>ES</Acronym><Agency>NIEHS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 HG009080</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL064658</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 NS048004</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 CA227237</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HG006399</GrantID><Acronym>HG</Acronym><Agency>NHGRI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K25 HL121295</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R03 DE025665</GrantID><Acronym>DE</Acronym><Agency>NIDCR NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>F31 NS122538</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>05</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Commun</MedlineTA><NlmUniqueID>101528555</NlmUniqueID><ISSNLinking>2041-1723</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073888">Cell-Free Nucleic Acids</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000465" MajorTopicYN="Y">Algorithms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001402" MajorTopicYN="N">B-Lymphocytes</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073888" MajorTopicYN="N">Cell-Free Nucleic Acids</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019175" MajorTopicYN="Y">DNA Methylation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044127" MajorTopicYN="Y">Epigenesis, Genetic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008264" MajorTopicYN="N">Macrophages</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009000" MajorTopicYN="N">Monocytes</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018482" MajorTopicYN="N">Muscle, Skeletal</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009504" MajorTopicYN="N">Neutrophils</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009928" MajorTopicYN="N">Organ Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011264" MajorTopicYN="N">Pregnancy Trimesters</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013601" MajorTopicYN="N">T-Lymphocytes</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>N.Z., B.L.B., B.C., and F.G. have a founding interest in Mercury Epigenomics, LLC, which was not directly or indirectly involved in any of these studies. All other authors report no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>5</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>3</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>5</Month><Day>12</Day><Hour>6</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>5</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>5</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33976150</ArticleId><ArticleId IdType="pmc">PMC8113516</ArticleId><ArticleId IdType="doi">10.1038/s41467-021-22901-x</ArticleId><ArticleId IdType="pii">10.1038/s41467-021-22901-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nagata S. Apoptosis by death factor. Cell. 1997;88:355&#x2013;365. doi: 10.1016/S0092-8674(00)81874-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(00)81874-7</ArticleId><ArticleId IdType="pubmed">9039262</ArticleId></ArticleIdList></Reference><Reference><Citation>Meier P, et al. Apoptosis in development. Nature. 2000;407:796&#x2013;801. doi: 10.1038/35037734.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/35037734</ArticleId><ArticleId IdType="pubmed">11048731</ArticleId></ArticleIdList></Reference><Reference><Citation>Joka D, et al. Prospective biopsy-controlled evaluation of cell death biomarkers for prediction of liver fibrosis and nonalcoholic steatohepatitis. Hepatology. 2012;55:455&#x2013;464. doi: 10.1002/hep.24734.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hep.24734</ArticleId><ArticleId IdType="pubmed">21993925</ArticleId></ArticleIdList></Reference><Reference><Citation>Vila M, Przedborski S. Targeting programmed cell death in neurodegenerative diseases. Nat. Rev. Neurosci. 2003;4:365&#x2013;375. doi: 10.1038/nrn1100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn1100</ArticleId><ArticleId IdType="pubmed">12728264</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner M, et al. Mechanisms, models and biomarkers in amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. frontotemporal Degener. 2013;14:19&#x2013;32. doi: 10.3109/21678421.2013.778554.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2013.778554</ArticleId><ArticleId IdType="pmc">PMC4284067</ArticleId><ArticleId IdType="pubmed">23678877</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowser R, et al. Biomarkers in amyotrophic lateral sclerosis: opportunities and limitations. Nat. Rev. Neurol. 2011;7:631&#x2013;638. doi: 10.1038/nrneurol.2011.151.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2011.151</ArticleId><ArticleId IdType="pubmed">21989244</ArticleId></ArticleIdList></Reference><Reference><Citation>Stroun M, et al. The origin and mechanism of circulating DNA. Ann. N. Y. Acad. Sci. 2000;906:161&#x2013;8. doi: 10.1111/j.1749-6632.2000.tb06608.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1749-6632.2000.tb06608.x</ArticleId><ArticleId IdType="pubmed">10818614</ArticleId></ArticleIdList></Reference><Reference><Citation>Laurent, D. et al Absolute measurement of the tissue origins of cell-free DNA in the healthy state and following paracetamol overdose. BMC Med. Genomics. 13(2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7133021</ArticleId><ArticleId IdType="pubmed">32252771</ArticleId></ArticleIdList></Reference><Reference><Citation>Kustanovich A, et al. Life and death of circulating cell-free DNA. Cancer Biol. Ther. 2019;20:1057&#x2013;1067. doi: 10.1080/15384047.2019.1598759.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15384047.2019.1598759</ArticleId><ArticleId IdType="pmc">PMC6606043</ArticleId><ArticleId IdType="pubmed">30990132</ArticleId></ArticleIdList></Reference><Reference><Citation>Jahr S, et al. DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res. 2001;61:1659&#x2013;1665.</Citation><ArticleIdList><ArticleId IdType="pubmed">11245480</ArticleId></ArticleIdList></Reference><Reference><Citation>Han X, et al. Circulating tumor DNA as biomarkers for cancer detection. Genom. Proteom. Bioinform. 2017;15:59&#x2013;72. doi: 10.1016/j.gpb.2016.12.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gpb.2016.12.004</ArticleId><ArticleId IdType="pmc">PMC5414889</ArticleId><ArticleId IdType="pubmed">28392479</ArticleId></ArticleIdList></Reference><Reference><Citation>Tug S, et al. Correlation between cell free DNA levels and medical evaluation of disease progression in systemic lupus erythematosus patients. Cell. Immunol. 2014;292:32&#x2013;39. doi: 10.1016/j.cellimm.2014.08.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellimm.2014.08.002</ArticleId><ArticleId IdType="pubmed">25243646</ArticleId></ArticleIdList></Reference><Reference><Citation>Vlaminck I, et al. Noninvasive monitoring of infection and rejection after lung transplantation. Proc. Natl Acad. Sci. USA. 2015;112:13336&#x2013;13341. doi: 10.1073/pnas.1517494112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1517494112</ArticleId><ArticleId IdType="pmc">PMC4629384</ArticleId><ArticleId IdType="pubmed">26460048</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf6;genur, M. et al. The role of total cell-free DNA in predicting outcomes among trauma patients in the intensive care unit: a systematic review. Crit. Care21, 14 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5260039</ArticleId><ArticleId IdType="pubmed">28118843</ArticleId></ArticleIdList></Reference><Reference><Citation>Musci T, et al. Non-invasive prenatal testing with cell-free DNA: US physician attitudes toward implementation in clinical practice. Prenatal Diagn. 2013;33:424&#x2013;428. doi: 10.1002/pd.4091.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pd.4091</ArticleId><ArticleId IdType="pubmed">23526649</ArticleId></ArticleIdList></Reference><Reference><Citation>Volik S, et al. Cell-free DNA (cfDNA): clinical significance and utility in cancer shaped by emerging technologies. Mol. Cancer Res. 2016;14:898&#x2013;908. doi: 10.1158/1541-7786.MCR-16-0044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1541-7786.MCR-16-0044</ArticleId><ArticleId IdType="pubmed">27422709</ArticleId></ArticleIdList></Reference><Reference><Citation>Taavitsainen S, et al. Evaluation of commercial circulating tumor DNA test in metastatic prostate cancer. JCO Precis. Oncol. 2019;3:1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7446428</ArticleId><ArticleId IdType="pubmed">32914020</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheridan C. Investors keep the faith in cancer liquid biopsies. Nat. Biotechnol. 2019;37:972&#x2013;974. doi: 10.1038/d41587-019-00022-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41587-019-00022-7</ArticleId><ArticleId IdType="pubmed">31485041</ArticleId></ArticleIdList></Reference><Reference><Citation>Lokk K, et al. DNA methylome profiling of human tissues identifies global and tissue-specific methylation patterns. Genome Biol. 2014;15:r54. doi: 10.1186/gb-2014-15-4-r54.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/gb-2014-15-4-r54</ArticleId><ArticleId IdType="pmc">PMC4053947</ArticleId><ArticleId IdType="pubmed">24690455</ArticleId></ArticleIdList></Reference><Reference><Citation>Houseman E, et al. DNA methylation arrays as surrogate measures of cell mixture distribution. BMC Bioinform. 2012;13:86. doi: 10.1186/1471-2105-13-86.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-13-86</ArticleId><ArticleId IdType="pmc">PMC3532182</ArticleId><ArticleId IdType="pubmed">22568884</ArticleId></ArticleIdList></Reference><Reference><Citation>Houseman E, et al. Reference-free cell mixture adjustments in analysis of DNA methylation data. Bioinformatics. 2014;30:1431&#x2013;1439. doi: 10.1093/bioinformatics/btu029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btu029</ArticleId><ArticleId IdType="pmc">PMC4016702</ArticleId><ArticleId IdType="pubmed">24451622</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahmani E, et al. Sparse PCA corrects for cell-type heterogeneity in epigenome-wide association studies. Nat. Methods. 2016;13:443&#x2013;445. doi: 10.1038/nmeth.3809.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.3809</ArticleId><ArticleId IdType="pmc">PMC5548182</ArticleId><ArticleId IdType="pubmed">27018579</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahmani E, et al. BayesCCE: a Bayesian framework for estimating cell-type composition from DNA methylation without the need for methylation reference. Genome Biol. 2018;9:141. doi: 10.1186/s13059-018-1513-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13059-018-1513-2</ArticleId><ArticleId IdType="pmc">PMC6151042</ArticleId><ArticleId IdType="pubmed">30241486</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehmann-Werman R, et al. Identification of tissue-specific cell death using methylation patterns of circulating DNA. Proc. Natl Acad. Sci. USA. 2016;113:E1826&#x2013;E1834. doi: 10.1073/pnas.1519286113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1519286113</ArticleId><ArticleId IdType="pmc">PMC4822610</ArticleId><ArticleId IdType="pubmed">26976580</ArticleId></ArticleIdList></Reference><Reference><Citation>Moss J, et al. Comprehensive human cell-type methylation atlas reveals origins of circulating cell-free DNA in health and disease. Nat. Commun. 2018;9:1&#x2013;12. doi: 10.1038/s41467-018-07466-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-07466-6</ArticleId><ArticleId IdType="pmc">PMC6265251</ArticleId><ArticleId IdType="pubmed">30498206</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X, et al. Comprehensive DNA methylation analysis of tissue of origin of plasma cell-free DNA by methylated CpG tandem amplification and sequencing (MCTA-Seq) Clin. Epigenet. 2019;11:93. doi: 10.1186/s13148-019-0689-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13148-019-0689-y</ArticleId><ArticleId IdType="pmc">PMC6591962</ArticleId><ArticleId IdType="pubmed">31234922</ArticleId></ArticleIdList></Reference><Reference><Citation>Snyder M, et al. Cell-free DNA comprises an in vivo nucleosome footprint that informs its tissues-of-origin. Cell. 2016;164:57&#x2013;68. doi: 10.1016/j.cell.2015.11.050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.11.050</ArticleId><ArticleId IdType="pmc">PMC4715266</ArticleId><ArticleId IdType="pubmed">26771485</ArticleId></ArticleIdList></Reference><Reference><Citation>Pidsley R, et al. Critical evaluation of the Illumina MethylationEPIC BeadChip microarray for whole-genome DNA methylation profiling. Genome Biol. 2016;17:208. doi: 10.1186/s13059-016-1066-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13059-016-1066-1</ArticleId><ArticleId IdType="pmc">PMC5055731</ArticleId><ArticleId IdType="pubmed">27717381</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang S, et al. CancerLocator: non-invasive cancer diagnosis and tissue-of-origin prediction using methylation profiles of cell-free DNA. Genome Biol. 2017;18:53. doi: 10.1186/s13059-017-1191-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13059-017-1191-5</ArticleId><ArticleId IdType="pmc">PMC5364586</ArticleId><ArticleId IdType="pubmed">28335812</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W, et al. CancerDetector: ultrasensitive and non-invasive cancer detection at the resolution of individual reads using cell-free DNA methylation sequencing data. Nucleic Acids Res. 2018;46:e89&#x2013;e89. doi: 10.1093/nar/gky423.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky423</ArticleId><ArticleId IdType="pmc">PMC6125664</ArticleId><ArticleId IdType="pubmed">29897492</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen S, et al. Sensitive tumour detection and classification using plasma cell-free DNA methylomes. Nature. 2018;563:579&#x2013;583. doi: 10.1038/s41586-018-0703-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0703-0</ArticleId><ArticleId IdType="pubmed">30429608</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatterton, Z. et al. Brain-derived circulating cell-free DNA defines the brain region and cell specific origins associated with neuronal atrophy. Preprint at 538827 (2019).</Citation></Reference><Reference><Citation>Verber, N. et al. Biomarkers in motor neuron disease: a state of the art review. Front. Neurol.10, 291 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6456669</ArticleId><ArticleId IdType="pubmed">31001186</ArticleId></ArticleIdList></Reference><Reference><Citation>Duchi, J. et al. Efficient projections onto the 1-Ball for learning in high dimensions. ICML&#x2019;08: Proceedings of the 25th international conference on Machine learning, pp. 272&#x2013;279 (ACM, New York, NY, USA, 2008).</Citation></Reference><Reference><Citation>Loyfer, N. nloyfer/meth_atlas. https://github.com/nloyfer/meth_atlas (2019).</Citation></Reference><Reference><Citation>Ziller M, et al. Coverage recommendations for methylation analysis by whole genome bisulfite sequencing. Nat. Methods. 2015;12:230&#x2013;232. doi: 10.1038/nmeth.3152.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.3152</ArticleId><ArticleId IdType="pmc">PMC4344394</ArticleId><ArticleId IdType="pubmed">25362363</ArticleId></ArticleIdList></Reference><Reference><Citation>The ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature489, 57&#x2013;74 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3439153</ArticleId><ArticleId IdType="pubmed">22955616</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis C, et al. The encyclopedia of DNA elements (ENCODE): data portal update. Nucleic Acids Res. 2018;46:D794&#x2013;D801. doi: 10.1093/nar/gkx1081.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkx1081</ArticleId><ArticleId IdType="pmc">PMC5753278</ArticleId><ArticleId IdType="pubmed">29126249</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez J, et al. The BLUEPRINT data analysis portal. Cell Syst. 2016;3:491&#x2013;495.e5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5919098</ArticleId><ArticleId IdType="pubmed">27863955</ArticleId></ArticleIdList></Reference><Reference><Citation>The ROADMAP Consortium. et al. Integrative analysis of 111 reference human epigenomes. Nature518, 317&#x2013;330 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4530010</ArticleId><ArticleId IdType="pubmed">25693563</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziller M, et al. Charting a dynamic DNA methylation landscape of the human genome. Nature. 2013;500:477&#x2013;481. doi: 10.1038/nature12433.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature12433</ArticleId><ArticleId IdType="pmc">PMC3821869</ArticleId><ArticleId IdType="pubmed">23925113</ArticleId></ArticleIdList></Reference><Reference><Citation>Auton A, et al. A global reference for human genetic variation. Nature. 2015;526:68&#x2013;74. doi: 10.1038/nature15393.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature15393</ArticleId><ArticleId IdType="pmc">PMC4750478</ArticleId><ArticleId IdType="pubmed">26432245</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf6;vkvist C, et al. DNA methylation in human epigenomes depends on local topology of CpG sites. Nucleic Acids Res. 2016;44:5123&#x2013;5132. doi: 10.1093/nar/gkw124.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkw124</ArticleId><ArticleId IdType="pmc">PMC4914085</ArticleId><ArticleId IdType="pubmed">26932361</ArticleId></ArticleIdList></Reference><Reference><Citation>Taglauer E, et al. Review: cell-free fetal DNA in the maternal circulation as an indication of placental health and disease. Placenta. 2014;35:S64&#x2013;S68. doi: 10.1016/j.placenta.2013.11.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.placenta.2013.11.014</ArticleId><ArticleId IdType="pmc">PMC4886648</ArticleId><ArticleId IdType="pubmed">24388429</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen T, et al. Whole genome bisulfite sequencing of cell-free DNA and its cellular contributors uncovers placenta hypomethylated domains. Genome Biol. 2015;16:78. doi: 10.1186/s13059-015-0645-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13059-015-0645-x</ArticleId><ArticleId IdType="pmc">PMC4427941</ArticleId><ArticleId IdType="pubmed">25886572</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogawa M. Differentiation and proliferation of hematopoietic stem cells. Blood. 1993;81:2844&#x2013;2853. doi: 10.1182/blood.V81.11.2844.2844.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.V81.11.2844.2844</ArticleId><ArticleId IdType="pubmed">8499622</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams J, et al. Epithelial cell shedding and barrier function. Vet.Pathol. 2015;52:445&#x2013;455. doi: 10.1177/0300985814559404.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0300985814559404</ArticleId><ArticleId IdType="pmc">PMC4441880</ArticleId><ArticleId IdType="pubmed">25428410</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun K, et al. Plasma DNA tissue mapping by genome-wide methylation sequencing for noninvasive prenatal, cancer, and transplantation assessments. Proc. Natl Acad. Sci. USA. 2015;112:E5503&#x2013;E5512. doi: 10.1073/pnas.1508736112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1508736112</ArticleId><ArticleId IdType="pmc">PMC4603482</ArticleId><ArticleId IdType="pubmed">26392541</ArticleId></ArticleIdList></Reference><Reference><Citation>Constantino B, Cogionis B. Nucleated RBCs&#x2014;significance in the peripheral blood film. Lab. Med. 2000;31:223&#x2013;229. doi: 10.1309/D70F-HCC1-XX1T-4ETE.</Citation><ArticleIdList><ArticleId IdType="doi">10.1309/D70F-HCC1-XX1T-4ETE</ArticleId></ArticleIdList></Reference><Reference><Citation>McGrath, C. et al. Total white blood cell counts for persons ages 1&#x2013;74 years with differential leukocyte counts for adults ages 25&#x2013;74 years: United States, 1971&#x2013;75. Vital Health Stat. Ser. 11 Data From the National Health Survey Series 11, No. 220, 1&#x2013;36 (1982). https://www.cdc.gov/nchs/data/series/sr_11/sr11_220.pdf.</Citation><ArticleIdList><ArticleId IdType="pubmed">7064358</ArticleId></ArticleIdList></Reference><Reference><Citation>Swarup V, Rajeswari M. Circulating (cell-free) nucleic acids&#x2014;a promising, non-invasive tool for early detection of several human diseases. FEBS Lett. 2007;581:795&#x2013;799. doi: 10.1016/j.febslet.2007.01.051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2007.01.051</ArticleId><ArticleId IdType="pubmed">17289032</ArticleId></ArticleIdList></Reference><Reference><Citation>Velders M, et al. Exercise is a potent stimulus for enhancing circulating DNase activity. Clin. Biochem. 2014;47:471&#x2013;474. doi: 10.1016/j.clinbiochem.2013.12.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinbiochem.2013.12.017</ArticleId><ArticleId IdType="pubmed">24373926</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwarzenbach H, et al. Cell-free nucleic acids as biomarkers in cancer patients. Nat. Rev. Cancer. 2011;11:426&#x2013;437. doi: 10.1038/nrc3066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrc3066</ArticleId><ArticleId IdType="pubmed">21562580</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang P, Lo Y. The long and short of circulating cell-free DNA and the ins and outs of molecular diagnostics. Trends Genet. 2016;32:360&#x2013;371. doi: 10.1016/j.tig.2016.03.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tig.2016.03.009</ArticleId><ArticleId IdType="pubmed">27129983</ArticleId></ArticleIdList></Reference><Reference><Citation>Li B, et al. A prospective study of total plasma cell-free DNA as a predictive biomarker for response to systemic therapy in patients with advanced non-small-cell lung cancers. Ann. Oncol. 2016;27:154&#x2013;159. doi: 10.1093/annonc/mdv498.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/annonc/mdv498</ArticleId><ArticleId IdType="pmc">PMC4684155</ArticleId><ArticleId IdType="pubmed">26487589</ArticleId></ArticleIdList></Reference><Reference><Citation>Pentsova E, et al. Evaluating cancer of the central nervous system through next-generation sequencing of cerebrospinal fluid. J. Clin. Oncol. 2016;34:2404&#x2013;2415. doi: 10.1200/JCO.2016.66.6487.</Citation><ArticleIdList><ArticleId IdType="doi">10.1200/JCO.2016.66.6487</ArticleId><ArticleId IdType="pmc">PMC4981784</ArticleId><ArticleId IdType="pubmed">27161972</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu M, et al. Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA. Ann. Oncol. 2020;31:745&#x2013;759. doi: 10.1016/j.annonc.2020.02.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.annonc.2020.02.011</ArticleId><ArticleId IdType="pubmed">33506766</ArticleId></ArticleIdList></Reference><Reference><Citation>Koker, A. et al. A versatile method for circulating cell-free DNA methylome profiling by reduced representation bisulfite sequencing. Preprint at 663195 (2019).</Citation></Reference><Reference><Citation>Shenhav L, et al. FEAST: fast expectation-maximization for microbial source tracking. Nat. Methods. 2019;16:627&#x2013;632. doi: 10.1038/s41592-019-0431-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41592-019-0431-x</ArticleId><ArticleId IdType="pubmed">31182859</ArticleId></ArticleIdList></Reference><Reference><Citation>Shim W, et al. Conserved epigenetic regulatory logic infers genes governing cell identity. Cell Syst. 2020;11:625&#x2013;639.e13. doi: 10.1016/j.cels.2020.11.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cels.2020.11.001</ArticleId><ArticleId IdType="pmc">PMC7781436</ArticleId><ArticleId IdType="pubmed">33278344</ArticleId></ArticleIdList></Reference><Reference><Citation>Pritchard J, et al. Inference of population structure using multilocus genotype data. Genetics. 2000;155:945&#x2013;959. doi: 10.1093/genetics/155.2.945.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/genetics/155.2.945</ArticleId><ArticleId IdType="pmc">PMC1461096</ArticleId><ArticleId IdType="pubmed">10835412</ArticleId></ArticleIdList></Reference><Reference><Citation>Virtanen P, et al. SciPy 1.0: fundamental algorithms for scientific computing in Python. Nat. Methods. 2020;17:261&#x2013;272. doi: 10.1038/s41592-019-0686-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41592-019-0686-2</ArticleId><ArticleId IdType="pmc">PMC7056644</ArticleId><ArticleId IdType="pubmed">32015543</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrews, S. s-andrews/FastQC. https://github.com/s-andrews/FastQC (2021).</Citation></Reference><Reference><Citation>Kent W, et al. The human genome browser at UCSC. Genome Res. 2002;12:996&#x2013;1006. doi: 10.1101/gr.229102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.229102</ArticleId><ArticleId IdType="pmc">PMC186604</ArticleId><ArticleId IdType="pubmed">12045153</ArticleId></ArticleIdList></Reference><Reference><Citation>Kosoy R, et al. Ancestry informative marker sets for determining continental origin and admixture proportions in common populations in America. Hum. Mutat. 2009;30:69&#x2013;78. doi: 10.1002/humu.20822.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/humu.20822</ArticleId><ArticleId IdType="pmc">PMC3073397</ArticleId><ArticleId IdType="pubmed">18683858</ArticleId></ArticleIdList></Reference><Reference><Citation>Seldin M, Price A. Application of ancestry informative markers to association studies in European Americans. PLoS Genet. 2008;4:e5. doi: 10.1371/journal.pgen.0040005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.0040005</ArticleId><ArticleId IdType="pmc">PMC2211545</ArticleId><ArticleId IdType="pubmed">18208330</ArticleId></ArticleIdList></Reference><Reference><Citation>Caggiano, C. christacaggiano/celfie. https://zenodo.org/record/4495826#.YBn1N3dKi3I (2021)</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>